News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
783,402 Results
Type
Article (58061)
Company Profile (396)
Press Release (724930)
Multimedia
Podcasts (120)
Webinars (19)
Section
Business (217362)
Career Advice (2255)
Deals (37392)
Drug Delivery (130)
Drug Development (85729)
Employer Resources (179)
FDA (17535)
Job Trends (16195)
News (368756)
Policy (36362)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2900)
Academic (1)
Accelerated approval (32)
Adcomms (31)
Allergies (147)
Alliances (53078)
ALS (176)
Alzheimer's disease (1758)
Antibody-drug conjugate (ADC) (328)
Approvals (17781)
Artificial intelligence (561)
Autoimmune disease (162)
Automation (39)
Bankruptcy (377)
Best Places to Work (12394)
BIOSECURE Act (23)
Biosimilars (196)
Biotechnology (256)
Bladder cancer (162)
Brain cancer (61)
Breast cancer (657)
Cancer (4986)
Cardiovascular disease (430)
Career advice (1914)
Career pathing (39)
CAR-T (293)
CDC (54)
Celiac Disease (2)
Cell therapy (778)
Cervical cancer (38)
Clinical research (72787)
Collaboration (1799)
Company closure (4)
Compensation (1183)
Complete response letters (61)
COVID-19 (2890)
CRISPR (97)
C-suite (880)
Cystic fibrosis (152)
Data (6317)
Decentralized trials (2)
Denatured (42)
Depression (145)
Diabetes (526)
Diagnostics (7048)
Digital health (45)
Diversity (13)
Diversity, equity & inclusion (47)
Drug discovery (265)
Drug pricing (214)
Drug shortages (33)
Duchenne muscular dystrophy (233)
Earnings (93843)
Editorial (62)
Employer branding (23)
Employer resources (157)
Events (126627)
Executive appointments (1019)
FDA (20741)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (10)
Frontotemporal dementia (24)
Funding (1536)
Gene editing (209)
Generative AI (51)
Gene therapy (641)
GLP-1 (1084)
Government (5271)
Grass and pollen (8)
Guidances (386)
Healthcare (20539)
HIV (60)
Huntington's disease (46)
IgA nephropathy (82)
Immunology and inflammation (272)
Immuno-oncology (60)
Indications (105)
Infectious disease (3169)
Inflammatory bowel disease (202)
Inflation Reduction Act (14)
Influenza (117)
Intellectual property (248)
Interviews (347)
IPO (17288)
IRA (56)
Job creations (4182)
Job search strategy (1611)
JPM (60)
Kidney cancer (16)
Labor market (83)
Layoffs (595)
Leadership (35)
Legal (8884)
Liver cancer (97)
Longevity (15)
Lung cancer (675)
Lymphoma (382)
Machine learning (44)
Management (59)
Manufacturing (825)
MASH (170)
Medical device (14881)
Medtech (14937)
Mergers & acquisitions (21182)
Metabolic disorders (1357)
Multiple sclerosis (163)
NASH (18)
Neurodegenerative disease (341)
Neuropsychiatric disorders (95)
Neuroscience (3047)
Neurotech (1)
NextGen: Class of 2026 (7199)
Non-profit (4916)
Now hiring (65)
Obesity (651)
Opinion (296)
Ovarian cancer (168)
Pain (208)
Pancreatic cancer (232)
Parkinson's disease (297)
Partnered (35)
Patents (501)
Patient recruitment (492)
Peanut (59)
People (62983)
Pharmaceutical (80)
Pharmacy benefit managers (32)
Phase 1 (22660)
Phase 2 (31870)
Phase 3 (23864)
Pipeline (5243)
Policy (313)
Postmarket research (2921)
Preclinical (9770)
Press Release (69)
Prostate cancer (249)
Psychedelics (50)
Radiopharmaceuticals (300)
Rare diseases (882)
Real estate (6545)
Recruiting (72)
Regulatory (26796)
Reports (51)
Research institute (2626)
Resumes & cover letters (378)
Rett syndrome (27)
RNA editing (20)
RSV (80)
Schizophrenia (156)
Series A (256)
Series B (195)
Service/supplier (13)
Sickle cell disease (104)
Special edition (24)
Spinal muscular atrophy (170)
Sponsored (44)
Startups (3978)
State (2)
Stomach cancer (20)
Supply chain (110)
Tariffs (93)
The Weekly (76)
Vaccines (1069)
Venture capital (91)
Weight loss (441)
Women's health (90)
Worklife (20)
Date
Today (97)
Last 7 days (597)
Last 30 days (2143)
Last 365 days (31418)
2026 (3073)
2025 (31795)
2024 (36995)
2023 (41957)
2022 (53295)
2021 (58056)
2020 (56884)
2019 (50124)
2018 (37966)
2017 (34647)
2016 (34784)
2015 (40787)
2014 (34445)
2013 (29914)
2012 (32113)
2011 (32743)
2010 (31831)
Location
Africa (895)
Alabama (91)
Alaska (7)
Arizona (323)
Arkansas (14)
Asia (44291)
Australia (7390)
California (11512)
Canada (3305)
China (1156)
Colorado (492)
Connecticut (499)
Delaware (341)
Europe (98417)
Florida (1706)
Georgia (369)
Hawaii (3)
Idaho (65)
Illinois (921)
India (66)
Indiana (538)
Iowa (23)
Japan (432)
Kansas (130)
Kentucky (40)
Louisiana (28)
Maine (72)
Maryland (1445)
Massachusetts (8419)
Michigan (340)
Minnesota (658)
Mississippi (6)
Missouri (131)
Montana (35)
Nebraska (28)
Nevada (127)
New Hampshire (85)
New Jersey (3110)
New Mexico (32)
New York (3049)
North Carolina (1584)
North Dakota (10)
Northern California (5574)
Ohio (342)
Oklahoma (23)
Oregon (45)
Pennsylvania (2311)
Puerto Rico (23)
Rhode Island (49)
South America (1269)
South Carolina (67)
South Dakota (1)
Southern California (4470)
Tennessee (175)
Texas (1800)
United States (41333)
Utah (342)
Vermont (1)
Virginia (278)
Washington D.C. (85)
Washington State (960)
West Virginia (4)
Wisconsin (116)
Wyoming (2)
783,402 Results for "med electronics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
TempraMed Launches New Product “VIVI Med(TM),” Unlocking New Growth Opportunities in High-Value Biologics and Injectable Medications
Using same proprietary, patented technology, VIVI Med extends the product portfolio beyond injectable pens, opening access to broader patient populations, premium biologics, and institutional channel
January 23, 2026
·
6 min read
Press Releases
Insilico Medicine Appoints Halle Zhang, PhD (Med), as Vice President, Clinical Development - Oncology
February 8, 2026
·
5 min read
Press Releases
IR-MED’s Key Clinical and Media Milestones
PressureSafe(TM) clinical results presented to global nursing leaders; the Company engages with U.S. investment community and national media in parallel visibility push
October 27, 2025
·
6 min read
Press Releases
Resonetics® Expands Bioelectronics Implant Offering with Acquisition of Manufacturing Assets and Process IP from Med-Ally
January 6, 2026
·
3 min read
Press Releases
Orano Med Enters Next Phase of Collaboration With Roche
December 4, 2025
·
5 min read
Press Releases
Therma Bright Sells an Additional 200-Units of Venowave(TM) to Strategic Distribution Partner Gen-X Med
January 20, 2026
·
1 min read
Press Releases
MedX Holdings, Inc. (OTC: MEDH) Med X Holdings Q2 2025 Investor Update: We’re at an Inflection Point
August 20, 2025
·
5 min read
Press Releases
Bio Green Med Solution Reports Third Quarter Financial Results and Provides Business Update
November 14, 2025
·
8 min read
Press Releases
MED Institute and Sus Clinicals Announce Strategic Collaboration to Advance Preclinical Testing for Medical Product Innovation
December 11, 2025
·
2 min read
Business
Kane Biotech Signs Worldwide License Agreement with Montreal-Based I-MED Pharma Inc.First Commercial Agreement for DispersinB®
Kane Biotech Inc. announces that it has entered into a worldwide license agreement with I-MED Pharma Inc. (“I-MED Pharma” or “I-MED”) for the DispersinB ® technology.
June 25, 2024
·
3 min read
1 of 78,341
Next
